145 related articles for article (PubMed ID: 38070048)
21. Triple assessment of sentinel lymph node metastasis in early breast cancer using preoperative CTLG, intraoperative fluorescence navigation and OSNA.
Mokhtar M; Tadokoro Y; Nakagawa M; Morimoto M; Takechi H; Kondo K; Tangoku A
Breast Cancer; 2016 Mar; 23(2):202-10. PubMed ID: 25069434
[TBL] [Abstract][Full Text] [Related]
22. Intraoperative prediction of the two axillary lymph node macrometastases threshold in patients with breast cancer using a one-step nucleic acid cytokeratin-19 amplification assay.
Fung V; Kohlhardt S; Vergani P; Zardin GJ; Williams NR
Mol Clin Oncol; 2017 Nov; 7(5):755-762. PubMed ID: 29142748
[TBL] [Abstract][Full Text] [Related]
23. Can axillary lymphadenectomy be avoided in breast cancer with positive sentinel lymph node biopsy? Predictors of non-sentinel lymph node metastasis.
Alcaide SM; Diana CAF; Herrero JC; Vegue LB; Perez AV; Arce ES; Sapiña JBB; Noguera PJG; Caravajal JMG
Arch Gynecol Obstet; 2022 Dec; 306(6):2123-2131. PubMed ID: 35503378
[TBL] [Abstract][Full Text] [Related]
24. Axillary staging based on molecular analysis: Results of the B-CLOSER-II study.
Sansano I; Vieites B; Sancho de Salas M; García C; Amendoeira I; Bernet L; Pérez-García JM; Espinosa-Bravo M; Rubio IT; Ramón Y Cajal S; Peg V
Pathol Res Pract; 2020 Nov; 216(11):153197. PubMed ID: 32919301
[TBL] [Abstract][Full Text] [Related]
25. One Step Nucleic Acid Amplification (OSNA) positive micrometastases and additional histopathological NSLN metastases: Results from a single institution over 53 months.
Babar M; Madani R; Jackson P; Layer GT; Kissin MW; Irvine TE
Surgeon; 2016 Apr; 14(2):76-81. PubMed ID: 25444440
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of Axillary Lymph Node Marking with Magseed® before and after Neoadjuvant Systemic Therapy in Breast Cancer Patients: MAGNET Study.
Martínez M; Jiménez S; Guzmán F; Fernández M; Arizaga E; Sanz C
Breast J; 2022; 2022():6111907. PubMed ID: 35855102
[TBL] [Abstract][Full Text] [Related]
27. Routine clinical use of the one-step nucleic acid amplification assay for detection of sentinel lymph node metastases in breast cancer patients: results of a multicenter study in Japan.
Tamaki Y; Sato N; Homma K; Takabatake D; Nishimura R; Tsujimoto M; Yoshidome K; Tsuda H; Kinoshita T; Kato H; Taniyama K; Kamio T; Nakamura S; Akiyama F; Noguchi S;
Cancer; 2012 Jul; 118(14):3477-83. PubMed ID: 22252672
[TBL] [Abstract][Full Text] [Related]
28. Sentinel node tumour burden quantified based on cytokeratin 19 mRNA copy number predicts non-sentinel node metastases in breast cancer: molecular whole-node analysis of all removed nodes.
Osako T; Iwase T; Kimura K; Horii R; Akiyama F
Eur J Cancer; 2013 Apr; 49(6):1187-95. PubMed ID: 23265708
[TBL] [Abstract][Full Text] [Related]
29. Positive non-sentinel axillary lymph nodes in breast cancer with 1-2 sentinel lymph node metastases.
Zheng J; Cai S; Song H; Wang Y; Han X; Wu H; Gao Z; Qiu F
Medicine (Baltimore); 2018 Nov; 97(44):e13015. PubMed ID: 30383658
[TBL] [Abstract][Full Text] [Related]
30. Role of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node low-volume metastasis in early-stage cervical cancer.
Bizzarri N; Pedone Anchora L; Zannoni GF; Santoro A; Valente M; Inzani F; Gallotta V; Conte C; Chiantera V; Fanfani F; Fagotti A; Ferrandina G; Scambia G
Int J Gynecol Cancer; 2020 Mar; 30(3):364-371. PubMed ID: 31980488
[TBL] [Abstract][Full Text] [Related]
31. A differential intra-operative molecular biological test for the detection of sentinel lymph node metastases in breast carcinoma. An extended experience from the first U.K. centre routinely offering the service in clinical practice.
Babar M; Madani R; Thwaites L; Jackson PA; Devalia HL; Chakravorty A; Irvine TE; Layer GT; Kissin MW
Eur J Surg Oncol; 2014 Mar; 40(3):282-8. PubMed ID: 24331309
[TBL] [Abstract][Full Text] [Related]
32. Prediction score model for non-sentinel and four or more nodal metastases using a combined method of one-step nucleic acid amplification and histology in sentinel node-positive breast cancer patients.
Jimbo K; Kinoshita T; Ogura T; Watase C; Murata T; Shiino S; Takayama S; Yoshida M
Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):516-521. PubMed ID: 31711717
[TBL] [Abstract][Full Text] [Related]
33. Detailed evaluation of one step nucleic acid (OSNA) molecular assay for intra-operative diagnosis of sentinel lymph node metastasis and prediction of non-sentinel nodal involvement: experience from a London teaching hospital.
Banerjee SM; Michalopoulos NV; Williams NR; Davidson T; El Sheikh S; McDermott N; Tran-Dang MA; Davison S; Keshtgar MR
Breast; 2014 Aug; 23(4):378-84. PubMed ID: 24630617
[TBL] [Abstract][Full Text] [Related]
34. One-step nucleic acid amplification assay for intraoperative prediction of advanced axillary lymph node metastases in breast cancer patients with sentinel lymph node metastasis.
Kubota M; Komoike Y; Hamada M; Shinzaki W; Azumi T; Hashimoto Y; Imoto S; Takeyama Y; Okuno K
Mol Clin Oncol; 2016 Feb; 4(2):173-178. PubMed ID: 26893855
[TBL] [Abstract][Full Text] [Related]
35. A prediction model for early systemic recurrence in breast cancer using a molecular diagnostic analysis of sentinel lymph nodes: A large-scale, multicenter cohort study.
Osako T; Matsuura M; Yotsumoto D; Takayama S; Kaneko K; Takahashi M; Shimazu K; Yoshidome K; Kuraoka K; Itakura M; Tani M; Ishikawa T; Ohi Y; Kinoshita T; Sato N; Tsujimoto M; Nakamura S; Tsuda H; Noguchi S; Akiyama F
Cancer; 2022 May; 128(10):1913-1920. PubMed ID: 35226357
[TBL] [Abstract][Full Text] [Related]
36. Using one-step nucleic acid amplification (OSNA) for intraoperative detection of lymph node metastasis in breast cancer patients avoids second surgery and accelerates initiation of adjuvant therapy.
Klingler S; Marchal F; Rauch P; Kenouchi O; Chrétien AS; Genin P; Leroux A; Merlin JL
Ann Oncol; 2013 Sep; 24(9):2305-9. PubMed ID: 23661291
[TBL] [Abstract][Full Text] [Related]
37. Risk factors and prognosis of sentinel lymph node metastasis in breast-conserving breast cancer: A retrospective study based on the SEER database.
Liu R; Chen J; Cao W; Li T; Liao Y; Li Y
Medicine (Baltimore); 2024 Mar; 103(9):e37263. PubMed ID: 38428869
[TBL] [Abstract][Full Text] [Related]
38. One-step nucleic acid amplification assay for intraoperative prediction of non-sentinel lymph node metastasis in breast cancer patients with sentinel lymph node metastasis.
Teramoto A; Shimazu K; Naoi Y; Shimomura A; Shimoda M; Kagara N; Maruyama N; Kim SJ; Yoshidome K; Tsujimoto M; Tamaki Y; Noguchi S
Breast; 2014 Oct; 23(5):579-85. PubMed ID: 24973902
[TBL] [Abstract][Full Text] [Related]
39. The real-time intra-operative evaluation of sentinel lymph nodes in breast cancer patients using One Step Nucleic Acid Amplification (OSNA) and implications for clinical decision-making.
Chaudhry A; Williams S; Cook J; Jenkins M; Sohail M; Calder C; Winters ZE; Rayter Z
Eur J Surg Oncol; 2014 Feb; 40(2):150-7. PubMed ID: 24378008
[TBL] [Abstract][Full Text] [Related]
40. Whole sentinel lymph node analysis by a molecular assay predicts axillary node status in breast cancer.
Ohi Y; Umekita Y; Sagara Y; Rai Y; Yotsumoto D; Matsukata A; Baba S; Tamada S; Matsuyama Y; Ando M; Sagara Y; Sasaki M; Tsuchimochi S; Tanimoto A; Sagara Y
Br J Cancer; 2012 Oct; 107(8):1239-43. PubMed ID: 22929881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
